Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
- PMID: 11463019
- PMCID: PMC1510901
- DOI: 10.1056/NEJM200107193450311
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
Comment in
-
Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.N Engl J Med. 2002 Jul 11;347(2):148-9. doi: 10.1056/NEJM200207113470221. N Engl J Med. 2002. PMID: 12110753 No abstract available.
References
-
- Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107(6B):2S–9S. - PubMed
-
- Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000;132:296–305. - PubMed
-
- McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485–92. - PubMed
-
- Normand J, Vlahov D, Moses LE, editors. Preventing HIV transmission: the role of sterile needles and bleach. National Academy Press; Washington, D.C.: 1995. - PubMed
-
- Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995;74:212–20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical